Estrella Immunopharma (ESLAW) Stock Chart & Stock Price History $0.04 0.00 (0.00%) As of 07/11/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock Estrella Immunopharma Stock Price Performance The Estrella Immunopharma (ESLAW) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 11.39%, with a year-to-date return of -56.37%. In the past month, the stock has decreased 30.14%, reflecting recent market activity. As of the latest close, Estrella Immunopharma traded at $0.04 with a market cap of and volume of 4,600 shares. Receive ESLAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.25%1 Month Performance-30.14%3 Month Performance-54.69%Year-To-Date Performance-56.37%1 Year PerformanceN/A ESLAW Stock Chart for Sunday, July, 13, 2025 ESLAW Chart by TradingView Estrella Immunopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$0.04$0.04$0.04$0.044,600 shs$0.0007/10/2025$0.04$0.04$0.04$0.044,600 shs$0.0007/09/2025$0.04$0.04+0.25%$0.04$0.044,666 shs$0.0007/08/2025$0.05$0.04-15.79%$0.04$0.04125 shs$0.0007/07/2025$0.05$0.05$0.05$0.05200 shs$0.0007/04/2025$0.05$0.05$0.05$0.05200 shs$0.0007/03/2025$0.05$0.05$0.05$0.05200 shs$0.0007/02/2025$0.05$0.05$0.05$0.05200 shs$0.0007/01/2025$0.05$0.05$0.05$0.05200 shs$0.0006/30/2025$0.05$0.05$0.05$0.05200 shs$0.00 Get the Latest News and Ratings for ESLAW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$0.04$0.05+31.58%$0.05$0.05216 shs$0.0006/26/2025$0.04$0.04-0.82%$0.04$0.041,750 shs$0.0006/25/2025$0.04$0.04$0.04$0.04800 shs$0.0006/24/2025$0.04$0.04-9.00%$0.04$0.04801 shs$0.0006/23/2025$0.04$0.04+2.56%$0.04$0.04127,620 shs$0.0006/20/2025$0.04$0.04$0.04$0.04700 shs$0.0006/19/2025$0.04$0.04$0.04$0.04704 shs$0.0006/18/2025$0.04$0.04-2.74%$0.04$0.04704 shs$0.0006/17/2025$0.05$0.04-17.66%$0.06$0.0478,463 shs$0.0006/16/2025$0.06$0.05-15.16%$0.05$0.05855 shs$0.0006/13/2025$0.05$0.06+7.49%$0.06$0.0514,794 shs$0.0006/12/2025$0.04$0.05+42.40%$0.05$0.03107,153 shs$0.00 Related Companies 180 Life Sciences Stock Chart 60 Degrees Pharmaceuticals Stock Chart Alpha Tau Medical Stock Chart Apollomics Stock Chart BriaCell Therapeutics Stock Chart Cardio Diagnostics Stock Chart Carmell Stock Chart Celularity Stock Chart CERo Therapeutics Stock Chart Cingulate Stock Chart Receive ESLAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ESLAW) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Estrella Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Estrella Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
